Drug Discovery Today

Neuroprotection in stroke: is it time to consider large-molecule drugs?
pp. 751-753(3)
Author: Pardridge W.M.

Cancer drug delivery is hot stuff
pp. 754-756(3)
Author: Habeck M.

Drug-free tolerance of transplanted tissue
pp. 756-757(2)
Author: Whelan J.

Electrifying new treatment for epilepsy
pp. 757-758(2)
Author: Fricker J.

News in brief
pp. 759-762(4)
Author: Lawrence R.N.

People
pp. 763-763(1)
Author: Lawrence R.N.

Personalia
pp. 764-765(2)
Author: Demidov V.V.

Animal models and human genome diversity: the pitfalls of inbred mice
pp. 766-768(3)
Authors: Gurwitz D.; Weizman A.

Gene therapy versus protein-based therapy: a matter of pharmacokinetics
pp. 769-770(2)
Authors: Post M.J.; Simons M.

Novel proteases for drug discovery
pp. 770-770(1)
Author: Moss M.

Transgenic gene knockouts: a functional platform for the industry
pp. 770-771(2)
Author: Sanseau P.

Proteomics: delivering new routes to drug discovery - Part 1
pp. 772-774(3)
Author: Jain K.K.

EuroBiochips: spot the difference!
pp. 775-777(3)
Author: Soloviev M.

Pharmacokinetic Optimization in Drug Research
pp. 778-778(1)
Authors: Pateman T.; Bayliss M.

The application of non-combinatorial chemistry to lead discovery
pp. 779-785(7)
Authors: Everett J.; Gardner M.; Pullen F.; Smith G.F.; Snarey M.; Terrett N.

Targeting the molecular mechanism of DNA replication
pp. 786-792(7)
Authors: Conti C.; Caburet S.; Bensimon A.

Receptor-mediated gene transfer by phage-display vectors: applications in functional genomics and gene therapy
pp. 793-801(9)
Authors: Larocca D.; Baird A.

Modelling and simulation in clinical drug development
pp. 802-806(5)
Authors: Rooney K.F.; Snoeck E.; Watson P.H.

Monitor: molecules and profiles
pp. 807-809(3)
Authors: Barlocco D.; Langston S.; Tranter D.

Drug delivery
pp. 809-810(2)
Author: Weidner J.

Combinatorial chemistry
pp. 810-811(2)
Author: Edwards P.